Sg Americas Securities, LLC Castle Biosciences Inc Transaction History
Sg Americas Securities, LLC
- $27.6 Billion
- Q3 2024
A detailed history of Sg Americas Securities, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 7,659 shares of CSTL stock, worth $204,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,659
Previous 26,989
71.62%
Holding current value
$204,188
Previous $588,000
62.93%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CSTL
# of Institutions
201Shares Held
24.5MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$81.2 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$48.7 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$46.6 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$33.6 Million0.61% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.26MShares$33.5 Million2.85% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $701M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...